Kilitch Drugs (India) Limited (NSE:KILITCH)
India · Delayed Price · Currency is INR 363.90
-2.25 (-0.61%)
Sep 12, 2025, 3:29 PM IST
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 5.80 billion as of September 12, 2025. Its market cap has increased by 6.14% in one year.
Market Cap
5.80B
Enterprise Value
5.68B
Revenue
2.08B
Ranking
n/a
PE Ratio
20.42
Stock Price
363.90
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 5.80B, an increase of 40,334.62%. That is a compound annual growth rate of 29.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 5.80B | 10.76% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | 1.49B | -24.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,819.02B |
| Divi's Laboratories | 1,593.48B |
| Cipla | 1,253.31B |
| Apollo Hospitals Enterprise | 1,125.19B |
| Mankind Pharma | 1,068.76B |
| Zydus Lifesciences | 1,042.06B |
| Fortis Healthcare | 716.91B |
| Alkem Laboratories | 638.00B |